Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease
- PMID: 20824818
- DOI: 10.1002/ibd.21457
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease
Abstract
Background: Clostridium difficile has emerged as an important pathogen in patients with inflammatory bowel disease (IBD) and is associated with increased morbidity and mortality. No studies have examined the temporal change in severity of C. difficile infection (CDI) complicating IBD.
Methods: Using data from the Nationwide Inpatient Sample, we identified all IBD-related hospitalizations during the years 1998, 2004, and 2007 and examined hospitalizations with a coexisting diagnosis of C. difficile. We compared the absolute outcomes of in-hospital mortality and colectomy in the C. difficile-IBD cohort during these timepoints, and also examined these outcomes relative to non-C. difficile IBD controls during each corresponding year.
Results: During 1998, 2004, and 2007, approximately 1.4%, 2.3%, and 2.9% of all IBD hospitalizations nationwide were complicated by CDI (P < 0.001). The absolute mortality in the C. difficile-IBD cohort increased from 5.9%-7.2% (P = 0.052) with a nonsignificant increase in colectomy rate from 3.8%-4.5% between 1998 and 2007. Compared to non-C. difficile IBD controls, there was an increase in the relative mortality risk associated with C. difficile from 1998 (odds ratio [OR] 2.38, 95% confidence interval [CI]: 1.52-3.72) to 2007 (OR 3.38, 95% CI: 2.66-4.29) (P = 0.15) with a significant increase in total colectomy odds from 1998 (OR 1.39, 95% CI: 0.81-2.37) to 2007 (OR 2.51, 95% CI: 1.90-3.34) (P = 0.03).
Conclusion: There has been a temporal increase nationwide in CDI complicating IBD hospitalizations. The excess morbidity associated with C. difficile infection in hospitalized IBD patients has increased between 1998 and 2007.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.
Similar articles
-
Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases.J Crohns Colitis. 2013 Mar;7(2):107-12. doi: 10.1016/j.crohns.2012.02.015. Epub 2012 Mar 21. J Crohns Colitis. 2013. PMID: 22440891
-
Clostridium difficile and inflammatory bowel disease.Inflamm Bowel Dis. 2008 Oct;14(10):1432-42. doi: 10.1002/ibd.20500. Inflamm Bowel Dis. 2008. PMID: 18484669 Review.
-
Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease.Inflamm Bowel Dis. 2013 Apr;19(5):1080-5. doi: 10.1097/MIB.0b013e3182807563. Inflamm Bowel Dis. 2013. PMID: 23478808
-
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29. Am J Gastroenterol. 2008. PMID: 18513271
-
Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease.Aliment Pharmacol Ther. 2017 Apr;45(8):1011-1020. doi: 10.1111/apt.13972. Epub 2017 Feb 16. Aliment Pharmacol Ther. 2017. PMID: 28206678 Review.
Cited by
-
Dormant Crohn's Disease Reactivated by Clostridioides difficile Infection.Cureus. 2023 Apr 3;15(4):e37062. doi: 10.7759/cureus.37062. eCollection 2023 Apr. Cureus. 2023. PMID: 37153283 Free PMC article.
-
Cytomegalovirus Infection Is Associated With Adverse Outcomes Among Hospitalized Pediatric Patients With Inflammatory Bowel Disease.Gastroenterology Res. 2023 Feb;16(1):1-8. doi: 10.14740/gr1588. Epub 2023 Feb 28. Gastroenterology Res. 2023. PMID: 36895701 Free PMC article.
-
Postoperative diarrhea in Crohn's disease: Pathogenesis, diagnosis, and therapy.World J Clin Cases. 2023 Jan 6;11(1):7-16. doi: 10.12998/wjcc.v11.i1.7. World J Clin Cases. 2023. PMID: 36687182 Free PMC article. Review.
-
The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases.Pathogens. 2022 Jul 21;11(7):819. doi: 10.3390/pathogens11070819. Pathogens. 2022. PMID: 35890064 Free PMC article. Review.
-
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.Inflamm Bowel Dis. 2023 May 2;29(5):744-751. doi: 10.1093/ibd/izac139. Inflamm Bowel Dis. 2023. PMID: 35792493 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical